Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
- Duragesic
- Ionsys
Canadian Brand Name
- APO-fentaYNL Matrix
- CO fentaYNL
- Mylan-fentaNYL Matrix Patch
- Ran-Fentanyl Matrix
- Ran-Fentanyl Transdermal System 100
- Ran-Fentanyl Transdermal System 25
- Ran-Fentanyl Transdermal System 50
- Ran-Fentanyl Transdermal System 75
- Sandoz Fentanyl Patch
- Teva Fentanyl 100
- Teva Fentanyl 12
Descriptions
Fentanyl skin patch is used to treat severe pain, including acute pain following surgery. Ionsys® is applied by your healthcare provider in a hospital setting after surgery for the short-term management of acute pain. Duragesic® is used for pain severe enough to require around-the-clock pain relief for a long period of time.
Fentanyl skin patch is also used to treat severe and persistent pain that requires an extended treatment period and when other pain medicines did not work well enough or cannot be tolerated.
The Duragesic® skin patch should not be used if you need pain medicine for just a short time, such as after dental surgery or tonsil surgery. Do not use the patch for mild pain or pain that occurs only once in a while.
Fentanyl is a strong opioid analgesic (pain medicine). It acts on the central nervous system (CNS) to relieve pain.
When an opioid medicine is used for a long time, it may become habit-forming, causing mental or physical dependence. However, under the close supervision of a healthcare provider, people who have continuing pain should not let the fear of dependence keep them from using opioids to relieve their pain. Mental dependence (addiction) is less likely to occur when opioids are used for this purpose. Physical dependence may lead to withdrawal symptoms if treatment is stopped suddenly. However, severe withdrawal symptoms can usually be prevented by gradually reducing the dose over a period of time before treatment is stopped completely.
This medicine is available only under a restricted distribution program called the Opioid Analgesic REMS (Risk Evaluation and Mitigation Strategy) program.
This product is available in the following dosage forms:
Portions of this document last updated: June 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.